ArticleOncology letters2020

xCT inhibitor sulfasalazine depletes paclitaxel-resistant tumor cells through ferroptosis in uterine serous carcinoma.

Akiko Sugiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.